Abstract:Respiratory syncytial virus (RSV) is a common respiratory pathogen that infects the human lungs and respiratory tract, often causing symptoms similar to the common cold. Vaccination is the most effective strategy for managing viral outbreaks. Currently, extensive efforts are focused on developing a vaccine for RSV. Traditional vaccine design typically involves using an attenuated form of the pathogen to elicit an immune response. In contrast, peptide-based vaccines (PBVs) aim to identify and chemically synthesize specific immunodominant peptides (IPs), known as T-cell epitopes (TCEs), to induce a targeted immune response. Despite their potential for enhancing vaccine safety and immunogenicity, PBVs have received comparatively less attention. Identifying IPs for PBV design through conventional wet-lab experiments is challenging, costly, and time-consuming. Machine learning (ML) techniques offer a promising alternative, accurately predicting TCEs and significantly reducing the time and cost of vaccine development. This study proposes the development and evaluation of eight hybrid ML predictive models created through the permutations and combinations of two classification methods, two feature weighting techniques, and two feature selection algorithms, all aimed at predicting the TCEs of RSV. The models were trained using the experimentally determined TCEs and non-TCE sequences acquired from the Bacterial and Viral Bioinformatics Resource Center (BV-BRC) repository. The hybrid model composed of the XGBoost (XGB) classifier, chi-squared (ChST) weighting technique, and backward search (BST) as the optimal feature selection algorithm (ChST-BST-XGB) was identified as the best model, achieving an accuracy, sensitivity, specificity, F1 score, AUC, precision, and MCC of 97.10%, 0.98, 0.97, 0.98, 0.99, 0.99, and 0.96, respectively. Additionally, K-fold cross-validation (KFCV) was performed to ensure the model's reliability and an average accuracy of 97.21% was recorded for the ChST-BST-XGB model. The results indicate that the hybrid XGBoost model consistently outperforms other hybrid approaches. The epitopes predicted by the proposed model may serve as promising vaccine candidates for RSV, subject to in vitro and in vivo scientific assessments. This model can assist the scientific community in expediting the screening of active TCE candidates for RSV, ultimately saving time and resources in vaccine development.

Viral Immunogenicity Prediction by Machine Learning Methods

VirusImmu: a novel ensemble machine learning approach for viral immunogenicity prediction

Predicting viral proteins that evade the innate immune system: a machine learning-based immunoinformatics tool

Predicting Immunogenicity Risk in Biopharmaceuticals

Hybrid Predictive Machine Learning Model for the Prediction of Immunodominant Peptides of Respiratory Syncytial Virus

DeepViral: prediction of novel virus–host interactions from protein sequences and infectious disease phenotypes

Prediction of viral oncoproteins through the combination of generative adversarial networks and machine learning techniques

Recent Advances in Machine Learning-Based Models for Prediction of Antiviral Peptides

A framework for predicting variable-length epitopes of human-adapted viruses using machine learning methods

Machine Learning Approaches for Predicting Virus-Human Protein-Protein Interactions: An Evaluation of Retroviral Interaction Networks

Predicting the immune escape of SARS-CoV-2 neutralizing antibodies upon mutation

Vaxi-DL: A web-based deep learning server to identify potential vaccine candidates

Dive into Machine Learning Algorithms for Influenza Virus Host Prediction with Hemagglutinin Sequences

Anti-virus Autobots: Predicting More Infectious Virus Variants for Pandemic Prevention through Deep Learning

Chemoinformatics and Machine Learning Approaches for Identifying Antiviral Compounds

Immunogenicity Prediction with Dual Attention Enables Vaccine Target Selection

Machine learning approaches for influenza A virus risk assessment identifies predictive correlates using ferret model in vivo data

Using Interpretable Machine Learning to Massively Increase the Number of Antibody-Virus Interactions Across Studies

Predicting the Binding of SARS-CoV-2 Peptides to the Major Histocompatibility Complex with Recurrent Neural Networks

VirusPredictor: XGBoost-based software to predict virus-related sequences in human data

Concepts and methods for predicting viral evolution